Dual Antiplatelet and Glycoprotein Inhibitors in Emergency PCI | SpringerLink
SOLACI | Latin American Society of Interventional Cardiology
Ticagrelor versus clopidogrel in acute myocardial infarction patients with multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health - ScienceDirect
Switching between P2Y12 inhibitors: Rationale, methods, and expected consequences - ScienceDirect
Dr. Sheila Sahni on X: "Algorithm for switching between oral P2Y12 inhibitors in the acute and chronic setting. (For the Figure: LD = loading dose; MD = maintenance dose) Source: 2017 ESC
Frontiers | Low-dose and standard-dose ticagrelor compared with clopidogrel in patients with acute coronary syndromes: A cohort study from china
Pharmacodynamic profiles of switching from ticagrelor to clopidogrel... | Download Scientific Diagram
PDF) Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina | ZAFER GÜVEN - Academia.edu
Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial | The BMJ
CHANGE DAPT: Study Contests Benefit of Ticagrelor Over Clopidogrel After PCI in ACS | tctmd.com
Therapeutic Window of Clopidogrel and Ticagrelor in Patients With Critical Limb-Threatening Ischemia - Ashwat S. Dhillon, Jorge Caro, Han Tun, David G. Armstrong, Vincent Rowe, David M. Shavelle, Leonardo C. Clavijo, 2020
Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial - The Lancet
JCM | Free Full-Text | Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
Incidence, predictors, and prognosis of premature discontinuation or switch of prasugrel or ticagrelor: the ATLANTIS - SWITCH study | Scientific Reports
Cardiac Diseases and Therapies ACUTE CORONARY SYNDROMES ANTIPLATELET THERAPY SWITCHING CLINICIAN GUIDE
JCDD | Free Full-Text | Dual Antiplatelet Therapy with Parenteral P2Y12 Inhibitors: Rationale, Evidence, and Future Directions
How to Switch from Clopidogrel to Prasugrel or Ticagrelor - ppt download
Switching mode between the P2Y 12 platelet receptor inhibitors, acute... | Download Scientific Diagram
![PDF] Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP-4 Study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ae91a35597a217964269e92ba07c5f12d8dc1709/3-Figure1-1.png "PDF] Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP-4 Study | Semantic Scholar")
PDF] Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP-4 Study | Semantic Scholar
Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease | Circulation
JCM | Free Full-Text | Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors Oral ... | GrepMed
International Expert Consensus on Switching Platelet P2Y<sub>12</sub> Receptorâ•fiInhibiting Therapies
